NASDAQ:GNCA
Delisted
Genocea Biosciences Stock News
$0.0001
+0 (+0%)
At Close: Apr 19, 2023
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
This year's LG OLED TVs set to be released soon with 8K - 9to5Toys
06:08pm, Wednesday, 11'th Mar 2020
New LG OLED TVs are set to hit the scene in a few weeks with 8K panels and a new 48-inch display. Pricing has yet to be announced.
2020 LG OLED and NanoCell TVs rollout globally with 8K, AI, and more
04:01am, Wednesday, 11'th Mar 2020
A lot of video watching these days are taking place on the small screens of our phones or at least on slightly larger laptop and desktop monitors. That change in consumer habits has prompted TV mak…
Critical Survey: Alector (NASDAQ:ALEC) versus Genocea Biosciences (NASDAQ:GNCA)
07:16am, Saturday, 07'th Mar 2020
Alector (NASDAQ:ALEC) and Genocea Biosciences (NASDAQ:GNCA) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, val
Atlas Cross Sport might just be worth a spot on your shopping list
12:00am, Friday, 06'th Mar 2020
If you’re in the market for a mid-sized SUV, the 2020 Volkswagen Atlas Cross Sport might just make your buying decision a bit more complicated.
UPDATE: Hearing Genocea Granted European Patent EP2665490 For 'Vaccines And Compositions Against Streptococcus Pneumoniae'
12:00am, Wednesday, 04'th Mar 2020The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
12:28pm, Friday, 28'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on Feb. 27)
Global Cord Blood Corp (...
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 26.) Co-Diagnostics Inc (NASDAQ: CODX ) Fat
Genocea to Present at the Cowen & Company 40th Annual Health Care Conference
09:05pm, Wednesday, 26'th Feb 2020
CAMBRIDGE, Mass., Feb. 26, 2020 -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced.
Edited Transcript of GNCA earnings conference call or presentation 13-Feb-20 1:30pm GMT
02:15am, Friday, 21'st Feb 2020
Q4 2019 Genocea Biosciences Inc Earnings Call
